Groundbreaking News in Biotech! Oruka Therapeutics Joins the Nasdaq Biotechnology Index
Oruka Therapeutics, a leading biotechnology firm specializing in innovative biologics for chronic skin disease treatment, is set to make waves by joining the esteemed Nasdaq